Bullish Case: PLTR's term structure is flat (~45-57% IV) with no vol-compression edge, and October 10-17 expiries price only ~45-50% IV despite a 49% ninety-day run to $187.48. Call flow leads (48% more calls than puts), Helium's bullish risk is 34% above bearish, and its density peaks at $190 vs the market's $190 but with fatter left tail discounting. Fresh Army $48.1M ammo-management and Maven momentum plus Zacks #1 estimates ($2.17B rev, +84% YoY) support a grind to $195-$205 into Q3 earnings.

Bearish Case: At 10.9x book and ~108x forward P/E after a 52% two-month melt-up, mean-reversion risk is extreme; PLTR is only +4.8% year-over-year despite the 90-day spike, signaling prior ceiling rejection near $190-$200. Helium's density shows a fat tail to $130-$150, NHS £330M break-clause politics (February 2027) and 'AI stretched thin' rotation headlines could trigger multiple compression, and elevated far-put IV (60-101%) confirms dealers pricing crash convexity.

Potential Outcomes:

1. Range $175-$200 mean-revert — flat term structure, return-surface ridge at small moves; P≈45%. Falsified by sustained closes outside band.
2. Bullish grind $195-$215 — call-flow skew + Q3 earnings (early Nov, IV jump at Nov 7 tenor 58-61%); P≈25%.
3. Correction $150-$170 — valuation reset, AI rotation, NHS/UK headline risk; P≈22%.
4. Tail crash <$145 — macro shock via SPY surface's red downside wing; P≈8%.

September 29, 2026